Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Regenxbio (RGNX) Tax Provisions (2018 - 2022)

Regenxbio (RGNX) has 5 years of Tax Provisions data on record, last reported at -$43000.0 in Q4 2022.

  • For Q4 2022, Tax Provisions fell 100.32% year-over-year to -$43000.0; the TTM value through Dec 2022 reached -$84000.0, down 100.63%, while the annual FY2023 figure was -$152000.0, 80.95% down from the prior year.
  • Tax Provisions reached -$43000.0 in Q4 2022 per RGNX's latest filing, down from -$41000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $13.4 million in Q4 2021 and bottomed at -$1.9 million in Q4 2019.
  • Average Tax Provisions over 5 years is $1.7 million, with a median of -$3000.0 recorded in 2020.
  • Peak YoY movement for Tax Provisions: soared 398.49% in 2020, then plummeted 1125.0% in 2022.
  • A 5-year view of Tax Provisions shows it stood at $1.6 million in 2018, then crashed by 218.69% to -$1.9 million in 2019, then skyrocketed by 398.49% to $5.7 million in 2020, then skyrocketed by 133.38% to $13.4 million in 2021, then crashed by 100.32% to -$43000.0 in 2022.
  • Per Business Quant database, its latest 3 readings for Tax Provisions were -$43000.0 in Q4 2022, -$41000.0 in Q1 2022, and $13.4 million in Q4 2021.